Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Novartis
Federal Trade Commission
Mallinckrodt
Fish and Richardson
Covington
Cipla
Merck
Cerilliant
AstraZeneca

Generated: August 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021840

« Back to Dashboard
NDA 021840 describes SEASONIQUE, which is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from three suppliers. There are four patents protecting this drug and one Paragraph IV challenge. Additional details are available on the SEASONIQUE profile page.

The generic ingredient in SEASONIQUE is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.

Summary for NDA: 021840

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:4
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 021840

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SEASONIQUE
ethinyl estradiol; levonorgestrel
TABLET;ORAL 021840 NDA AUTHORIZED GENERIC Teva Pharmaceuticals USA ,Inc. 0093-3134 0093-3134-82 2 POUCH in 1 CARTON (0093-3134-82) > 1 BLISTER PACK in 1 POUCH (0093-3134-91) > 1 KIT in 1 BLISTER PACK
SEASONIQUE
ethinyl estradiol; levonorgestrel
TABLET;ORAL 021840 NDA Teva Women's Health, Inc. 51285-087 51285-087-87 2 POUCH in 1 CARTON (51285-087-87) > 1 BLISTER PACK in 1 POUCH (51285-087-82) > 1 KIT in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.03MG,0.01MG;0.15MG,N/A
Approval Date:May 25, 2006TE:ABRLD:Yes
Patent:► SubscribePatent Expiration:Jun 23, 2023Product Flag?YSubstance Flag?Delist Request?
Patent:► SubscribePatent Expiration:Jun 15, 2023Product Flag?Substance Flag?Delist Request?
Patented Use:PREVENTION OF PREGNANCY
Patent:► SubscribePatent Expiration:Dec 5, 2028Product Flag?Substance Flag?Delist Request?
Patented Use:PREVENTION OF PREGNANCY


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
QuintilesIMS
Moodys
Express Scripts
UBS
Chubb
Fuji
McKinsey
Accenture
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot